Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**RNU6ATAC7P** ("RNA, U6atac small nuclear 7, pseudogene") is annotated as a **pseudogene** related to the U6atac family of small nuclear RNAs, which are components of the minor spliceosome involved in splicing of a rare class of introns in pre-mRNA. Unlike its functional counterparts, which participate in pre-mRNA splicing as part of the spliceosome, the pseudogene **RNU6ATAC7P** lacks evidence of protein-coding or functional noncoding RNA expression and is not known to have a direct biological function. Pseudogenes in general are often considered non-functional genomic elements—though in some cases, pseudogene-derived RNAs can regulate gene expression in cancer and other conditions (e.g., by acting as microRNA decoys)—there is no such evidence for RNU6ATAC7P. It is not regarded as a therapeutic target, does not interact with drugs, and is not known to have any biomarker or safety relevance.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6atac small nuclear 7, pseudogene (RNU6ATAC7P).